Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling
Name:
s11689-021-09361-6.pdf
Size:
674.0Kb
Format:
PDF
Description:
Final Published Version
Author
Thurman, A.J.Edgin, J.O.
Sherman, S.L.
Sterling, A.
McDuffie, A.
Berry-Kravis, E.
Hamilton, D.
Abbeduto, L.
Affiliation
Department of Psychology, University of ArizonaIssue Date
2021Keywords
Clinical trialsDown syndrome
Expressive language
Expressive language sampling
Outcome measures
Psychometrics
Treatment
Metadata
Show full item recordPublisher
BioMed Central LtdCitation
Thurman, A.J., Edgin, J.O., Sherman, S.L. et al. Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling. J Neurodevelop Disord 13, 13 (2021).Rights
Copyright © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background: The purpose of this study was to evaluate expressive language sampling (ELS) as a procedure for generating spoken language outcome measures for treatment research in Down syndrome (DS). We addressed (a) feasibility, (b) practice effects across two short-term administrations, (c) test-retest reliability across two short-term administrations, (d) convergent and discriminant construct validity, and (e) considered comparisons across the conversation and narration contexts. Method: Participants were 107 individuals with DS between 6 and 23 years of age who presented with intellectual disability (IQ < 70). The utility of ELS procedures designed to collect samples of spoken language in conversation and narration were evaluated separately. Variables of talkativeness, vocabulary, syntax, utterance planning, and articulation quality, derived from transcripts segmented into C-units (i.e., an independent clause and its modifiers), were considered. A 4-week interval was used to assess practice effects and test-retest reliability. Standardized direct assessments and informant report measures were collected to evaluate construct validity of the ELS variables. Results: Low rates of noncompliance were observed; youth who were under 12 years of age, had phrase-level speech or less, and had a 4-year-old developmental level or less were at particular risk for experiencing difficulty completing the ELS procedures. Minimal practice effects and strong test-retest reliability across the 4-week test-retest interval was observed. The vocabulary, syntax, and speech intelligibility variables demonstrated strong convergent and discriminant validity. Although significant correlations were found between the variables derived from both the conversation and narration contexts, some differences were noted. Conclusion: The ELS procedures considered were feasible and yielded variables with adequate psychometric properties for most individuals with DS between 6 and 23 years old. That said, studies of outcome measures appropriate for individuals with DS with more limited spoken language skills are needed. Context differences were observed in ELS variables suggest that comprehensive evaluation of expressive language is likely best obtained when utilizing both contexts. © 2021, The Author(s).Note
Open access journalISSN
1866-1947PubMed ID
33827417Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1186/s11689-021-09361-6
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License.
Related articles
- Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity.
- Authors: Abbeduto L, Berry-Kravis E, Sterling A, Sherman S, Edgin JO, McDuffie A, Hoffmann A, Hamilton D, Nelson M, Aschkenasy J, Thurman AJ
- Issue date: 2020 Mar 24
- Expressive language sampling and outcome measures for treatment trials in fragile X and down syndromes: composite scores and psychometric properties.
- Authors: Abbeduto L, Del Hoyo Soriano L, Berry-Kravis E, Sterling A, Edgin JO, Abdelnur N, Drayton A, Hoffmann A, Hamilton D, Harvey DJ, Thurman AJ
- Issue date: 2023 Jun 7
- Using telehealth-delivered procedures to collect a parent-implemented expressive language sampling narrative task in monolingual and bilingual families with Autism Spectrum Disorder: A pilot study.
- Authors: Soriano LDH, Bullard L, Alvarez CH, Thurman AJ, Abbeduto L
- Issue date: 2021 Nov
- Expressive language development in adolescents with Down syndrome and fragile X syndrome: change over time and the role of family-related factors.
- Authors: Del Hoyo Soriano L, Thurman AJ, Harvey D, Kover ST, Abbeduto L
- Issue date: 2020 Jun 27
- The association between expressive language skills and adaptive behavior in individuals with Down syndrome.
- Authors: Del Hoyo Soriano L, Villarreal JC, Sterling A, Edgin J, Berry-Kravis E, Hamilton DR, Thurman AJ, Abbeduto L
- Issue date: 2022 Nov 21